首页> 外文期刊>Drug safety: An international journal of medical toxicology and drug experience >A potential event-competition bias in safety signal detection: Results from a spontaneous reporting research database in France
【24h】

A potential event-competition bias in safety signal detection: Results from a spontaneous reporting research database in France

机译:安全信号检测中潜在的事件竞争偏差:来自法国自发报告研究数据库的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Background: In spontaneous reporting databases, reports of well-established drug-event associations may mask alerts that arise from other drugs (drug competition bias). However, a symmetrical event-competition bias has not yet been explored whereby known events may mask an association with new events for a given drug or drug class. Objective: The objective of this study was to explore the effects of event-competition bias on safety signals generated from spontaneous reporting databases. Methods: The drug classes tested included statins, oral anticoagulants, antipsychotics and HIV antiretrovirals. For each, a type A reaction was selected, and its potential competitive effect on the generation of other safety signals for the drug was explored. These were rhabdomyolysis/myopathy for statins, haemorrhage for oral anticoagulants, extrapyramidal syndrome for antipsychotics and lipodystrophy for HIV antiretrovirals. Signals of disproportionate reporting (SDRs) were detected using the caseon-case approach in the French research spontaneous reporting database (which contains reports from 1 January 1986 to 31 December 2001), before and after removing all reports concerning these competitor events. SDRs were considered as potential signals if not reported in the literature before 1 January 2002 but confirmed since. Results: The whole database included 207,236 reports, 4,355 of which included statins as one of the suspected drugs. The removal of reports of rhabdomyolysis/myopathy concerned 8,425 reports among which 867 involved statins. After this removal, 11 new SDRs appeared for statins that had not been detected initially. Similarly, 15 SDRs were unmasked for oral anticoagulants, six for antipsychotics and nine for HIV antiretrovirals. After literature-based assessment, five of the 41 unmasked SDRs appeared related to potential safety signals confirmed after 2002. Conclusion: This study demonstrated that a masking phenomenon resulting from an event-competition effect could occur when performing signal detection using disproportionality analyses of spontaneous reporting databases. This should be taken into account when routine signal detection is performed.
机译:背景:在自发报告数据库中,建立良好的药物事件关联的报告可能掩盖了其他药物引起的警报(药物竞争偏好)。然而,尚未探索对称事件竞争偏差,由此已知事件可能掩盖给定药物或药物类别与新事件的关联。目的:本研究的目的是探讨事件竞争偏见对自发报告数据库产生的安全信号的影响。方法:测试的药物类别包括他汀类药物,口服抗凝药,抗精神病药和HIV抗逆转录病毒药。对于每种药物,均选择A型反应,并探讨其对药物产生其他安全信号的潜在竞争作用。它们是他汀类药物的横纹肌溶解/肌病,口服抗凝剂的出血,抗精神病药的锥体外系综合征和HIV抗逆转录病毒药的脂肪营养不良。在删除所有关于这些竞争对手事件的报告之前和之后,使用法国研究自发报告数据库(包含1986年1月1日至2001年12月31日的报告)中的案例/非案例方法检测到不成比例的报告信号。如果在文献中未在2002年1月1日之前报告过SDR,则SDR被认为是潜在的信号,但此后得到了证实。结果:整个数据库包含207,236份报告,其中4,355份包括他汀类药物作为可疑药物之一。消除横纹肌溶解/肌病的报告涉及8,425份报告,其中867份涉及​​他汀类药物。删除之后,针对他汀类药物的11种新SDR出现了,但最初并未发现。同样地,口服抗凝剂未发现15种SDR,抗精神病药为6种,HIV抗逆转录病毒药为9种。经过基于文献的评估,在2002年之后确认的41种未掩盖的SDR中,有五种与潜在的安全信号有关。结论:本研究表明,使用自发报告的不成比例分析进行信号检测时,可能会发生由事件竞争效应引起的掩盖现象。数据库。执行常规信号检测时应考虑到这一点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号